Volunteer for Research on Depression
in New York City.

Click here for information about many studies at Columbia University / New Your Psychiatric Institute
Study One: Genetics of Early Onset Recurrent Major Depression Study

There are many causes of major depression. One strategy for understanding possible genetic causes involves comparing the DNA from blood of brothers and sisters who suffer from this illness.

Eligibility criteria for a genetic study of major depression ongoing at Columbia University include: major depression before age 30; a living brother or sister who also has had major depression; age 21-70 . Subjects will be asked to participate in an interview and to donate a small amount of blood. Participants will be paid for their efforts.

If you think you may be eligible and would be interested in talking with a member of our professional staff confidentially about this study, please contact:

Simona Noaghiul, MD, MPH
New York State Psychiatric Institute, Unit 24
New York, NY 10032
Ph: (212) 543-6520

http://www.nyspi.org/depression/

Email: noaghius@child.cpmc.columbia.edu

The same study as above in Philadelphia.

Study Two: (NYC) Free treatment for 5 months in a research setting

Do you wish there were better treatment for depression?

With your help, there might be.

If you are depressed and between age 18-65, you may be eligible for a research study involving brain imaging and medication treatment at NO COST, to you at The New York State Psychiatric Institute/Columbia University. We will provide 5 months of outpatient treatment for Major Depressive Disorder at NO COST, to you as part of a treatment study. Your participation in this study can help further our understanding of depression and speed the recovery of others who suffer from depression in the future. Inpatient treatment is also available. You will be paid up to $415 for your time and effort if you are eligible and choose to participate.

For more information, please call (212) 543-1427 or visit our website.


Study Three: Bipolar CHOICE Study at Cornell Medical Center in New York City

This federally funded study is being conducted at ten different medical centers across the United States in individuals 18-68 years of age, diagnosed with bipolar I or II disorder and having at least mild current symptoms. The study will test whether lithium or quetiapine (Seroquel) in combination with other medications usually prescribed for bipolar disorder is more effective. Participants must be willing to be randomized to take lithium or Seroquel. This study lasts up to 6 months. Visits are once every 2 weeks for the first 2 months and then monthly thereafter. Study participants will receive study-related treatment, research medication and evaluation at no cost. Subjects receive $50 per visit For more information please call the Affective Disorders Research Clinic at Weill Cornell Medical Center.

Contact:

Courtney Shelly

Phone: 212-746-5705

Email: cos2003@med.cornell.edu

Return to Depression Central

Revised 27 March 2012